FDA.reportPublic FDA data

Application 090896

Type
ANDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CHLOROTHIAZIDE SODIUMCHLOROTHIAZIDE SODIUMINJECTABLE;INJECTIONEQ 500MG BASE/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
63323-658ChlorothiazideCHLOROTHIAZIDE SODIUMFresenius Kabi USA, LLCANDACurrent
63323-658ChlorothiazideCHLOROTHIAZIDE SODIUMFresenius Kabi USA, LLCANDACurrent
63323-658ChlorothiazideCHLOROTHIAZIDE SODIUMFresenius Kabi USA, LLCANDACurrent
63323-658ChlorothiazideCHLOROTHIAZIDE SODIUMFresenius Kabi USA, LLCANDACurrent
63323-658ChlorothiazideCHLOROTHIAZIDE SODIUMFresenius Kabi USA, LLCANDACurrent
63323-658ChlorothiazideCHLOROTHIAZIDE SODIUMFresenius Kabi USA, LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
31504ORIG2009-10-26